Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:05 AM
Ignite Modification Date:
2025-12-25 @ 5:05 AM
NCT ID:
NCT00732927
Eligibility Criteria:
Inclusion Criteria:
* Age between 18 and 85 years
* A body weight of greater than 50 Kg
* A requirement that no more than 15 days had passed between symptomatic presentation, confirmation of RVO and entry into the study.
Exclusion Criteria:
* Modification of the optic media transparency that could compromise the evaluation of fluorescein angiography, such as cataract or corneal degeneration
* History of major ocular surgery (with the exclusion of cataract extraction)
* Previous RVO
* Other ocular conditions that, in the opinion of the investigator, could have affected macular edema or altered visual acuity during the course of the study - Contraindications to the study drugs (e.g. major bleeding or neurosurgical procedures in the previous 3 months, serum creatinine levels of greater than 2.0 mg/dL, severe liver insufficiency, platelet count \< 100,000 mm3, known active peptic gastric ulcer)
* Active malignancy
* Pregnancy
* Inability to attend for follow up or anticipated non-compliance
* Ongoing treatment with aspirin or anticoagulant drugs at the time of RVO diagnosis
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT00732927
Study Brief:
Protocol Section:
NCT00732927